By Daniella Parra Creyon Bio, Inc. and Cajal Neuroscience have teamed up to develop therapies for neurodegenerative diseases, they said. The companies aim to accelerate the development of treatments for common neurodegenerative disorders, engineering medicines using human data and...

By Daniella Parra Agilent Technologies Inc. (NYSE: A)  appointed Padraig McDonnell as its new CEO, following a planned transition, the company said. McDonnell’s leadership experience and deep understanding of the company’s diversified business within Agilent, including driving growth and enhancing...

By Exec Edge Editorial Staff Executive Edge sat down with Geoffroy van Raemdonck, CEO of Neiman Marcus Group, in an exclusive Q&A session. Tell us about Neiman Marcus Group – what sets you apart in the luxury retail space? At...

Sir Lynton Crosby, Executive Chairman of CT Group By Exec Edge Editorial Staff There’s a moment in every election campaign when you can feel the scales tip toward the eventual winner, when a meaningful message breaks through and the public...

By Rob Chang, CEO & Director of Gryphon Digital Mining Inc. (Nasdaq: GRYP) At the start of January 2024, the Bitcoin mining sector hit a significant milestone with its sustainable energy usage peaking at over 50%. This achievement is more...

From left to right: Kate Sylvester, Scott Deveau and Rebecca Kral.   By Karen Roman Longacre Square Partners named two new partners and appointed a COO, people familiar with the matter told CorpGov. The communications and special situations advisory firm...

By Karen Roman Agendia, Inc.’s BluePrint was recently included in the latest version of German Gynecological Oncology Group (AGO) guidelines for chemotherapy decision making. AGO is comprised of gynecological oncologists specialized in breast cancer and interdisciplinary members focused on pathology,...

By Daniella Parra Gameto, a female-led biotechnology firm, said it received tentative FDA approval to move to Phase 3 trials for Fertilo, a pivotal step towards Biologic License Application approval, the company said. The primary efficacy endpoint will assess pregnancy...

By Karen Roman Orthobond Corp. said the Food and Drug Administration approved its request to market Ostaguard, an antibacterial surface treatment used on permanent spine implants. This is the first time the FDA granted approval for a medical device with...

By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS), a clinical-stage biopharmaceutical company, announced it signed an agreement with global pharmaceutical and biotech partner Lonza. The collaboration includes the manufacturing of sabirnetug (ACU193), an antibody for the treatment of Alzheimer’s disease...